Literature DB >> 21122412

[Natural progression of early esophageal squamous cell carcinoma].

Guo-qing Wang1, Wen-qiang Wei, Chang-qing Hao, Jun-hui Zhang, Ning Lü.   

Abstract

OBJECTIVE: The survival time of untreated advanced esophageal squamous cell carcinoma is about 8 - 9 months. The objective of this study was to observe the natural progression of untreated early esophageal squamous cell carcinoma for 20 years.
METHODS: 4800 subjects from a high risk area of esophageal cancer in Lin-zhou city, Henan province, were examined by endoscopy from 1985 to 1990. Among them, 132 cases were diagnosed as early esophageal cancer. Based on the criteria, the lesions were endoscopically diagnosed as superficial mucosal lesions and histopathologically confirmed by biopsy as carcinoma in situ, intramucosal carcinoma or squamous cell carcinoma. 48 of the 132 patients, who refused treatment, were followed up to the end of 2005. There were 43 death and 5 alive. 40 patients were re-examined for 1 - 4 times by endoscopy during the following up.
RESULTS: A total of 48 patients have been followed up for 20 years. 38 (79.2%) cases died of esophageal squamous cell carcinoma, 5 (10.4%) died of non-cancer diseases and 5 (10.4%) were surviving. 37 patients had survived for over 5 years. The 5-, 10-, 15- and 20-years survival rates were 77.1%, 39.6%, 25.0% and 10.4%, respectively.
CONCLUSION: The natural history of esophageal squamous cell carcinoma takes a long time to progress from early to advanced stage. It is very helpful for early diagnosis and selection of opportunity for treatment. The leading time bias by natural history of this disease should be considered when evaluate therapeutic effect on early stage esophageal cancer.

Entities:  

Mesh:

Year:  2010        PMID: 21122412

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  4 in total

1.  Rate of missed oesophageal cancer at routine endoscopy and survival outcomes: A multicentric cohort study.

Authors:  Enrique Rodríguez de Santiago; Nerea Hernanz; Héctor Miguel Marcos-Prieto; Miguel Ángel De-Jorge-Turrión; Eva Barreiro-Alonso; Carlos Rodríguez-Escaja; Andrea Jiménez-Jurado; María Sierra-Morales; Isabel Pérez-Valle; Nadja Machado-Volpato; María García-Prada; Laura Núñez-Gómez; Andrés Castaño-García; Ana García García de Paredes; Beatriz Peñas; Enrique Vázquez-Sequeiros; Agustín Albillos
Journal:  United European Gastroenterol J       Date:  2018-10-31       Impact factor: 4.623

2.  Descriptive analysis of esophageal cancer in Zambia using the cancer disease hospital database: young age, late stage at presentation.

Authors:  Akwi Wasi Asombang; Nancy Kasongo; John Muyutu; Joao Filipe Goncalves Montiero; Nathaniel Chishinga; Jackson Chipaila; Lewis Banda
Journal:  Pan Afr Med J       Date:  2021-05-04

3.  Epidemic trend, screening, and early detection and treatment of cancer in Chinese population.

Authors:  Xiao-Nong Zou
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

4.  Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China.

Authors:  Qiong Chen; Liang Yu; Changqing Hao; Jinwu Wang; Shuzheng Liu; Meng Zhang; Shaokai Zhang; Lanwei Guo; Peiliang Quan; Patrick Germain; Yawei Zhang; Xibin Sun
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.